The MyDOE Analysis Platform is an enterprise-grade AI and Bayesian optimization platform developed by Moonelisa Technology LLC. Designed specifically for biotechnology, bioprocess development, drug formulation, and advanced manufacturing R&D, it bridges classical experimental design with modern artificial intelligence.
Key Capabilities Integrated Methodologies: Combines classical Design of Experiments (DOE) workflows with generative AI prompt designing and Bayesian active learning surrogate models. R&D Optimization: Streamlines complex, multi-variable experimental spaces to accelerate discovery and enhance process efficiency.